QRXPHARMA LIMITED

QRxPharma Updates MOXDUO® NDA Review

[2013-06-26] - New Information to Delay Planned FDA Advisory Committee Meeting and PDUFA date

---

QRxPharma Granted US Patent On Hybrid Opioids

[2013-06-12] - Composition of Matter Patent Provides Coverage Until 2031

---

FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting

[2013-05-17] - Committee to Review Respiratory Safety Data Comparing MOXDUO with Components

---